Compare BLDR & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLDR | FMS |
|---|---|---|
| Founded | 1998 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 14.2B |
| IPO Year | 2005 | N/A |
| Metric | BLDR | FMS |
|---|---|---|
| Price | $82.47 | $22.52 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 18 | 2 |
| Target Price | ★ $132.29 | $30.00 |
| AVG Volume (30 Days) | ★ 2.3M | 471.9K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.57% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.89 | N/A |
| Revenue | ★ $15,190,638,000.00 | N/A |
| Revenue This Year | $1.00 | $1.41 |
| Revenue Next Year | $4.52 | $4.11 |
| P/E Ratio | $20.28 | ★ $15.62 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $78.55 | $20.96 |
| 52 Week High | $151.03 | $30.46 |
| Indicator | BLDR | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 36.60 | 47.87 |
| Support Level | $80.00 | $22.50 |
| Resistance Level | $130.47 | $24.08 |
| Average True Range (ATR) | 3.54 | 0.34 |
| MACD | 0.27 | 0.01 |
| Stochastic Oscillator | 30.35 | 53.92 |
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.